• The Daily Trade
  • Posts
  • Clearwater Analytics Makes Waves with $1.5 Billion Enfusion Acquisition & 76ers Shift Plans: New Arena in South Philly with Comcast Partnership

Clearwater Analytics Makes Waves with $1.5 Billion Enfusion Acquisition & 76ers Shift Plans: New Arena in South Philly with Comcast Partnership

The Daily Trade delivers sharp, daily insights on the US stock market.

Stay informed, spot trends, and trade with confidence.

Recent Headlines

Clearwater Analytics Expands Horizons with $1.5 Billion Enfusion Acquisition
Clearwater Analytics is making waves in the financial software sector with its $1.5 billion acquisition of Enfusion. This strategic move aims to enhance Clearwater's offerings and tap into the hedge fund market, showcasing the growing trend of mergers that create complementary services in the industry.
76ers Arena Plans Take a Turn: New Vision for Philadelphia's Sports Scene
In a surprising change of course, the Philadelphia 76ers have partnered with Comcast to build a new arena in South Philadelphia, abandoning plans for a downtown venue. This decision promises to invigorate the local economy and reaffirms the team's commitment to its fans and the city, all while aiming to attract a WNBA team.
Boston Beer Innovates with New Non-Alcoholic Offerings Amid Industry Challenges
Boston Beer is shaking things up with its innovative approach to non-alcoholic beverages. The launch of new products like Emerald Hour and Truly Vodka Seltzer reflects the company's strategy to revive its brand strength and adapt to changing consumer preferences, all while navigating the complexities of the beverage market.
In a surprising twist, Howard Hughes Holdings has confirmed an unsolicited acquisition proposal from Pershing Square. With the investment firm eyeing a majority stake, the market is abuzz with speculation about the potential changes this could bring to the real estate giant's operations. The board's special committee is now tasked with evaluating this intriguing offer!
Danaher's CEO is set to share insights on the company's fourth-quarter performance at an upcoming healthcare conference. While revenue growth is expected to be modest, the company anticipates exceeding previous guidance, leaving investors eager for more details on their strategic direction in the healthcare sector.
Intuitive Surgical finds itself in the spotlight as analysts revise price targets and ratings following recent stock activity. With a mix of insider selling and positive earnings reports, investors are keenly watching how this leading medical equipment provider navigates the market landscape.


Technical Analysis Results



Undervalued
STZ
Constellation Brands, Inc.
Volume: 5.5M shares | Price: $185.91

30 Day Performance
30-Day Price History

Technical Indicator Score: 100% Buy
Out of the 8 technical indicators that were used to analyze this stock, 8 indicated buy signals.
RSI
Buy
MFI
Buy
WillR
Buy
AO
Buy
CCI
Buy
BBANDS
Buy
ULTOSC
Buy
STOCH
Buy

Recent Mentions of STZ






Undervalued
QSR
Restaurant Brands International Inc.
Volume: 1.9M shares | Price: $60.94

30 Day Performance
30-Day Price History

Technical Indicator Score: 88% Buy
Out of the 8 technical indicators that were used to analyze this stock, 7 indicated buy signals, 1 indicated a neutral signal.
RSI
Buy
MFI
Hold
WillR
Buy
AO
Buy
CCI
Buy
BBANDS
Buy
ULTOSC
Buy
STOCH
Buy

Recent Mentions of QSR






Undervalued
INDA
iShares MSCI India ETF
Volume: 5.8M shares | Price: $50.65

30 Day Performance
30-Day Price History

Technical Indicator Score: 88% Buy
Out of the 8 technical indicators that were used to analyze this stock, 7 indicated buy signals, 1 indicated a neutral signal.
RSI
Buy
MFI
Buy
WillR
Buy
AO
Buy
CCI
Buy
BBANDS
Buy
ULTOSC
Hold
STOCH
Buy

Recent Mentions of INDA






Undervalued
MCY
Mercury General Corp.
Volume: 2.2M shares | Price: $47.18

30 Day Performance
30-Day Price History

Technical Indicator Score: 88% Buy
Out of the 8 technical indicators that were used to analyze this stock, 7 indicated buy signals, 1 indicated a neutral signal.
RSI
Buy
MFI
Buy
WillR
Buy
AO
Buy
CCI
Buy
BBANDS
Buy
ULTOSC
Hold
STOCH
Buy

Recent Mentions of MCY






Overvalued
CRGY
Crescent Energy Company
Volume: 3.4M shares | Price: $16.41

30 Day Performance
30-Day Price History

Technical Indicator Score: 88% Sell
Out of the 8 technical indicators that were used to analyze this stock, 7 indicated sell signals, 1 indicated a neutral signal.
RSI
Sell
MFI
Sell
WillR
Sell
AO
Sell
CCI
Sell
BBANDS
Sell
ULTOSC
Hold
STOCH
Sell

Recent Mentions of CRGY






Undervalued
HDB
HDFC Bank Limited
Volume: 3.5M shares | Price: $58.06

30 Day Performance
30-Day Price History

Technical Indicator Score: 75% Buy
Out of the 8 technical indicators that were used to analyze this stock, 6 indicated buy signals, 2 indicated neutral signals.
RSI
Buy
MFI
Buy
WillR
Buy
AO
Buy
CCI
Buy
BBANDS
Buy
ULTOSC
Hold
STOCH
Hold

Recent Mentions of HDB






Check out our partners!

We’ve teamed up with a few like-minded newsletters to bring you even more fresh insights and fun. If you’re craving extra knowledge, entertainment, and/or inspiration in your inbox, give them a look below!

1. Pour Decisions - Your sommelier-approved excuse to open another bottle. Get weekly wine recommendations from top sommeliers across the world.

2. Labrador - Discover high-return real estate deals daily with Labrador— the ultimate bird dog for smart investors.

3. Quip - A daily dose of jokes, trivia, and inspiration to brighten your day.

We want to hear from YOU!

Technical indicator analysis feedback request

Your feedback is important to us. We’re always looking for ways to improve and would love to hear your thoughts on how we can make this newsletter even better for you. Whether you have suggestions, ideas, or just want to share what you enjoy most, we’re all ears.

Simply reply to this email with your thoughts. Every comment helps us serve you better.

Thank you for being a valued reader.

How would you rate today's newsletter?

If there's anything I can do better, please let me know so I can make improvements!

Login or Subscribe to participate in polls.

Let’s stay in touch!

Thank you for reading today’s edition of The Daily Trade.

Let’s connect on LinkedIn!

-Ryan Serkes

Subscribe here if this email was forwarded to you!

Technical Indicator Information

Relative Strength Index (RSI) | Period: 14 days | Overvalued threshold: 70 | Undervalued threshold: 30

Money Flow Index (MFI) | Period: 14 days | Overvalued threshold: 80 | Undervalued threshold: 20

Williams Percent Range (WillR) | Period: 14 days | Overvalued threshold: -20 | Undervalued threshold: -80

Aroon Oscillator (AO) | Period: 14 days | Overvalued threshold: 75 | Undervalued threshold: -75

Moving Average Convergence/Divergence (MACD) | Period: 26/12/9 days | Overvalued threshold: MACD crosses below MACD Signal | Undervalued threshold: MACD crosses above MACD Signal

Stochastic Oscillator (STOCH) | Period: 14/3/3 days | Overvalued threshold: %K crosses below %D above 80 | Undervalued threshold: %K crosses above %D below 20

Commodity Channel Index (CCI) | Period: 20 days | Overvalued threshold: 100 | Undervalued threshold: -100

Bollinger Bands (BBANDS) | Period: 20 days | Overvalued threshold: price >= upper band | Undervalued threshold: price <= lower band

Parabolic Stop and Reverse (SAR) | Period: variable 50 - 100 days | Overvalued threshold: SAR crosses above price | Undervalued threshold: SAR crosses below price

Triple Exponential Average (TRIX) | Period: 15 days | Overvalued threshold: TRIX crosses below 0 | Undervalued threshold: TRIX crosses above 0

Ultimate Oscillator (ULTOSC) | Period: 28/14/7 days | Overvalued threshold: 70 | Undervalued threshold: 30

Directional Movement Index (DMI) | Period: 14 days | Overvalued threshold: PlusDI crosses below MinusDI | Undervalued threshold: PlusDI crosses above MinusDI

Average Directional Index (ADX) | Period: variable 14 days | Requirement: >= 25

Analysis is only performed on securities with market caps in excess of $100 million and with daily trade volume in excess of $50 million.

Disclaimers

The information in our newsletter is not intended to constitute investment advice and is not designed to meet your personal financial situation. It is provided for information purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor or a group of investors. It should not be assumed that any investments in securities, companies, sectors or markets identified and described will be profitable. We strongly advise you to discuss your investment options with your financial advisor prior to making any investments, including whether any investment is suitable for your specific needs.

Although we obtain information contained in our newsletter from sources we believe to be reliable, we cannot guarantee its accuracy. The analysis provided in this newsletter is based on the prior trading day’s closing prices and may not reflect after-hours trading, earnings announcements, or other significant market events that occur outside regular trading hours. As such, any data or commentary may not fully capture the latest market movements or emerging factors. For the most current and comprehensive view, please consider additional sources or consult with a qualified financial professional.

The information provided in our newsletter is private, privileged, and confidential information, licensed for your sole individual use as a subscriber. We reserve all rights to the content of this newsletter. Forwarding, copying, disseminating, or distributing this newsletter in whole or in part, including substantial quotation of any portion the publication or any release of specific investment recommendations, is strictly prohibited.